Published • loading... • Updated
Establishment and characterization of two gemcitabine-resistant cholangiocarcinoma cell lines
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Establishment and characterization of two gemcitabine-resistant cholangiocarcinoma cell lines
Cholangiocarcinoma (CCA) features high malignancy, concealed early symptoms and poor overall survival. Gemcitabine (GEM) plus cisplatin in combination with immune checkpoint inhibitors is a first-line chemotherapy regimen for advanced biliary tract cancer, yet acquired drug resistance severely...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
